316 related articles for article (PubMed ID: 36569293)
21. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors.
Ding Q; Li R; Wang Q; Yu L; Zi F
Front Oncol; 2023; 13():1049147. PubMed ID: 38053661
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
Tripathi A; Lin E; Xie W; Flaifel A; Steinharter JA; Stern Gatof EN; Bouchard G; Fleischer JH; Martinez-Chanza N; Gray C; Mantia C; Thompson L; Wei XX; Giannakis M; McGregor BA; Choueiri TK; Agarwal N; McDermott DF; Signoretti S; Harshman LC
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33177176
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of the novel omicron receptor AXL in cancers.
Zhang WN; Li XP; Wang PF; Zhu L; Xiao XH; Dai YJ
Comput Struct Biotechnol J; 2022; 20():3304-3312. PubMed ID: 35782741
[TBL] [Abstract][Full Text] [Related]
24. A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer.
Liu P; Liu Z; Luo Q; Fu Q; Zhang X; Yu P; Zhou S; Wang Y; Zhang J; Chen S; Zhang H; Zhu Q; Qin T
Sci Rep; 2023 Aug; 13(1):13898. PubMed ID: 37626178
[TBL] [Abstract][Full Text] [Related]
25. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts.
Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C
Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value and immunological role of cathepsin S gene in pan‑cancer.
Liang S; Dang B; Chen S; Mi H
Oncol Lett; 2024 Jan; 27(1):41. PubMed ID: 38108072
[TBL] [Abstract][Full Text] [Related]
27. Pan-cancer analysis reveals the pro-oncogenic role of N6-methyladenosine (m6A)-regulated NTMT1 in head and neck squamous cell carcinoma.
Zhao C; Yu M; Li Y
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23603. PubMed ID: 38014887
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and immunological role of cancer-associated fibroblasts-derived exosomal protein in esophageal squamous cell carcinoma.
Wang Z; Zhang M; Liu L; Yang Y; Qiu J; Yu Y; Li J
Int Immunopharmacol; 2023 Nov; 124(Pt A):110837. PubMed ID: 37634448
[TBL] [Abstract][Full Text] [Related]
29. The value of
Feng Y; Wang Y; Guo K; Feng J; Shao C; Pan M; Ding P; Liu H; Duan H; Lu D; Wang Z; Zhang Y; Zhang Y; Han J; Li X; Yan X
Ann Transl Med; 2022 Apr; 10(8):466. PubMed ID: 35571400
[TBL] [Abstract][Full Text] [Related]
30. Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistance.
Huang L; Irshad S; Sultana U; Ali S; Jamil A; Zubair A; Sultan R; Abdel-Maksoud MA; Mubarak A; Almunqedhi BM; Almanaa TN; Malik A; Alamri A; Kodous AS; Mares M; Zaky MY; Saba Sajjad S; Hameed Y
Am J Transl Res; 2024; 16(3):873-888. PubMed ID: 38586106
[TBL] [Abstract][Full Text] [Related]
31. Role of Kinetochore Scaffold 1 (KNL1) in Tumorigenesis and Tumor Immune Microenvironment in Pan-Cancer: Bioinformatics Analyses and Validation of Expression.
Ding Y; Wang K; Zhao S; Li Y; Qiu W; Zhu C; Wang Y; Dong C; Liu J; Lu Y; Qi W
Int J Gen Med; 2023; 16():4883-4906. PubMed ID: 37928953
[TBL] [Abstract][Full Text] [Related]
32. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
Front Genet; 2022; 13():989719. PubMed ID: 36212154
[No Abstract] [Full Text] [Related]
33. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer.
Mi J; Luo J; Zeng H; Zhang H; Jamil M; Abdel-Maksoud MA; Zakri AM; Alfuraydi AA; Zhang N; Xiao M
Am J Transl Res; 2023; 15(10):6026-6041. PubMed ID: 37969191
[TBL] [Abstract][Full Text] [Related]
34. Association analysis of FXYD5 with prognosis and immunological characteristics across pan-cancer.
Bai Y; Li L; Li J; Lu X
Heliyon; 2024 May; 10(9):e30727. PubMed ID: 38774095
[TBL] [Abstract][Full Text] [Related]
35. MARCO is a potential prognostic and immunotherapy biomarker.
Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment.
Zhao Y; Zhang M; Pu H; Guo S; Zhang S; Wang Y
Front Oncol; 2020; 10():585961. PubMed ID: 33552963
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhang W; Cao W; Tong Z; Jin Q; Jiang X; Yang Y; Yao H; Chen G; Gao W; Zhu Y; Zhou S
Front Oncol; 2022; 12():1011000. PubMed ID: 36185274
[TBL] [Abstract][Full Text] [Related]
38. Identifying the oncogenic roles of FAP in human cancers based on systematic analysis.
Ma C; Xi S; Sun H; Zhang M; Pei Y
Aging (Albany NY); 2023 Jul; 15(14):7056-7083. PubMed ID: 37490719
[TBL] [Abstract][Full Text] [Related]
39. Detailed analysis of adenosine A2a receptor (
Vogt TJ; Gevensleben H; Dietrich J; Kristiansen G; Bootz F; Landsberg J; Goltz D; Dietrich D
Oncoimmunology; 2018; 7(8):e1452579. PubMed ID: 30221045
[No Abstract] [Full Text] [Related]
40. A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment.
Gong X; Zheng C; Jia H; Liu Y; Yang R; Chen Z; Pan Y; Li X; Liu Y
BMC Cancer; 2023 Nov; 23(1):1065. PubMed ID: 37932706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
